Laurion Capital Management LP
Overview
Laurion Capital Management LP, established in 2005 by Benjamin A. Smith and Sheehan Maduraperuma, is a hedge fund based in New York City. The firm specializes in global markets, emphasizing relative value and macro strategies. Laurion Capital employs a multi-disciplinary approach, combining quantitative and qualitative analysis to allocate assets across a diverse range of investments in fixed income, commodities, and public equity markets globally. As of March 2024, the firm manages discretionary assets totaling approximately $12.5 billion. The firm's investment portfolio is diversified across various sectors, with significant holdings in consumer discretionary, finance, information technology, utilities and telecommunications, energy, health care, consumer staples, and materials. Notable portfolio companies include Aardvark Therapeutics, Leap Therapeutics, Pyxis Oncology, Pepgen, COMPASS Pathways, MerQube, Axoni, Opensee, Recursion Pharmaceuticals, and Solid Biosciences. Laurion Capital Management LP caters exclusively to pooled investment vehicles, taking advisory fees from a percentage of assets and various performance-based fees.
Investment Focus
- Accredited investors only
- Long-term investment horizon
- Diversified portfolio across asset classes
- Compliance with regulatory requirements
Portfolio Companies
Reach Laurion Capital Management LP directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Laurion Capital Management LP
What sectors does Laurion Capital Management LP invest in?
Laurion Capital Management LP invests in Energy, Materials, Finance, Health Care, Information Technology and Consumer Staples, and is based in New York, New York, United States. Laurion Capital Management LP is listed as a hedge fund in the ConnectSafely investor database.
What stage does Laurion Capital Management LP invest at?
Laurion Capital Management LP backs companies at Growth, Late Stage, Pre-IPO, Buyout, Turnaround and Distressed, writing cheques of 1M - 500M.
Which regions does Laurion Capital Management LP invest in?
Laurion Capital Management LP invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
Who are the partners at Laurion Capital Management LP?
Team members listed for Laurion Capital Management LP include Masih Mohebbi (Chief Financial Officer) and Hannah Pitt (Vice President of Investor Relations).
What companies has Laurion Capital Management LP invested in?
Laurion Capital Management LP's portfolio includes Axoni, Aardvark Therapeutics, Leap Therapeutics, Pyxis Oncology, Pepgen, COMPASS Pathways, MerQube and Opensee.
How do I contact Laurion Capital Management LP?
Laurion Capital Management LP's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
